The first study by the Health Services Research Network, revealed some new facts regarding the health care scenario in the USA. Among the other findings, the study cited growing complexity and costs of treating type 2 diabetes. The greater availability of new, innovative oral antidiabetic and insulin medications, as well as the increased use of combination therapies to treat patients with diabetes, contributed to these trends.
The study, “National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007,” documents the dramatic growth of Americans diagnosed with type 2 diabetes — from 11 million patients in 2000 to an expected 29 million by 2050.To conduct the analysis, the authors used IMS’s National Disease and Therapeutic Index to analyze medications prescribed between 1994 and 2007 for all U.S. office visits among patients 35 years and older with type 2 diabetes.
IMS’s National Prescription Audit database also was utilized to assess medication costs between 2001 and 2007.
To access a summary of the diabetes study, go to: https://archinte.ama-assn.org/cgi/content/short/168/19/2088. More information about IMS’s work with Health Services Research Network members, academic research affiliates, university students and non-profit organizations can be found at: https://www.imshealth.com/researchsupport.
Source: Trading Markets.com